Anti-TrkB antibodies

US10793634B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Rolf Herrmann · Biberach, DE
• Remko Alexander BAKKER · Biberach an der Riß, DE
• Sebastian Bandholtz · Schemmerhofen, DE
• Peter Michael Benz · Veitshöchheim, DE
• Michael Dziegelewski · Newburgh, US
• Lore Florin · Biberach, DE
• Cynthia Hess Kenny · Pearl River, US
• Sarah Low · Carmel, US
• Holger Rosenbrock · Mittelbiberach, DE
• Sanjaya Singh · Sandy Hook, US
• Heiko Friedrich STAHL · Biberach, DE
• Sathyadevi VENKATARAMANI · Blue Bell, US
• Vladimir H. Voynov · Danbury, US
• Haiguang Xiao · Ridgefield, US

Key dates

• Filing date: Jun 7, 2018
• Grant date: Oct 6, 2020
• Expiry date: Jun 7, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/94
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel agonistic anti-TrkB antibodies and therapeutic and diagnostic methods and compositions for using the same.